- Category
- Micro (2023-24)
- Udyam number
- UDYAM-TS-20-0018117

About Credas Labs Private Limited
Data last updated:
Credas Labs Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 02 June 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24100TG2021PTC151978. Its GSTIN is 36AAJCC5210C1Z6 (Telangana).
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹48.35 Lakh. It is led by directors Shiva Krishna Makam and Mahesh Kumar Ganji.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Sy No.201/1&2 B.N. Reddy Nagar, Hayathnagar Hyderabad, Telangana, India – 500070.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.16 Cr, a decline of 58% compared to the previous year. For the same year it recorded a net profit of ₹50,492 (net margin 0.4%) and EBITDA of ₹15.71 Lakh (EBITDA margin 13.5%).
As per MCA filings, the company has open charges of ₹1.9 Cr on record.
Credas Labs Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0018117). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website credaslabs.com.
Company details
Recognitions & Rankings of Credas Labs
Contact details
Credas Labs Private Limited's registered office is in Hyderabad, Telangana. Its website is credaslabs.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressSy No.201/1&2 B.N. Reddy Nagar, Hayathnagar Hyderabad, Telangana, India – 500070
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Credas Labs Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Credas Labs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Credas Labs Private Limited, buy the company report.
Financials of Credas Labs Private Limited
FY 2024 filings availableCredas Labs Private Limited reported revenue of ₹1.16 Cr (down 58% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 58% in the latest year. EBITDA rose 231% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹15.71 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹50,492 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 13.5% | ||
| Net Profit Margin | 0.4% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Credas Labs Private Limited, buy the company report.
Board of directors of Credas Labs Private Limited
Credas Labs has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shiva Krishna Makam Also directs: Makved Chemical Private Limited | Director | 29 Nov 2022 | 3 Years 10 Months | Current |
| Mahesh Kumar Ganji Also directs: Makved Chemical Private Limited | Director | 29 Nov 2022 | 3 Years 10 Months | Current |
Peer comparison
Credas Labs Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Inspeed Formulations Private Limited | ₹1.16 Cr (FY 2025) | -36.0% | Jaipur, Rajasthan, India | |||
| Credas Labs Private Limitedthis company | ₹1.16 Cr (FY 2024) | ₹50,492 | 0.4% | -58.0% | Hyderabad, Telangana, India | |
| Meghnagar Pharmachem Private Limited | ₹1.16 Cr (FY 2023) | -92.0% | Vadodara, Gujarat, India | |||
| Xenosys Biotech Private Limited | ₹1.15 Cr (FY 2025) | -42.0% | Sanand, Gujarat, India |
To see the full peer comparison of Credas Labs Private Limited, buy the company report.
Auditor
Credas Labs Private Limited is audited by YK REDDY AND ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| YK REDDY AND ASSOCIATES | FY 2023 | 215787 |
Shareholding
The shareholding of Credas Labs Private Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Credas Labs Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 24 Jun 2024 | 100941127 | Canara Bank | ₹1.9 Cr | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Credas Labs Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Credas Labs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Credas Labs Private Limited has 1 active EPFO establishment as of Apr 09, 2024.
GST
Credas Labs has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAJCC5210C1Z6 | Telangana | Active | 19 Jul 2021 |
To see the full GST registrations and return filing status of Credas Labs Private Limited, buy the company report.
Recent activity
Credas Labs Private Limited has 7 board changes on record since 2021: 2 appointments and 5 cessations. The latest: Reddy Karri K V Sridhar ceased to be Additional Director on 30 Nov 2022.
Frequently asked questions
Credas Labs is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 02 June 2021 (5+ years old) and is registered under CIN U24100TG2021PTC151978.
Credas Labs has 2 current directors:
- Shiva Krishna Makam - Director
- Mahesh Kumar Ganji - Director
The latest financial statements of Credas Labs on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Credas Labs is 36AAJCC5210C1Z6, registered in Telangana.
The CIN (Corporate Identification Number) of Credas Labs is U24100TG2021PTC151978. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Credas Labs was incorporated on 02 June 2021, making it 5+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Credas Labs by revenue are Inspeed Formulations Private Limited, Meghnagar Pharmachem Private Limited, Xenosys Biotech Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Reddy Karri K V Sridhar ceased to be Additional Director on 30 Nov 2022. Venkatesh Goud Donikena ceased to be Additional Director on 30 Nov 2022. Mahesh Kumar Ganji was appointed as Director on 29 Nov 2022. Credas Labs has 7 board changes on record in total.
Yes, Credas Labs is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-20-0018117).
Credas Labs can be reached through the website credaslabs.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Credas Labs is at Sy No.2011&2 B.N. Reddy Nagar, Hayathnagar Hyderabad, Telangana, India – 500070.